Rifat Pamukcu

Insider Reports History

Entity
Individual
Location
535 Boylston Street, Boston, MA
Signature
/s/ John Hamill, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rifat Pamukcu:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aprea Therapeutics, Inc. Director Common Stock 14.1K $103K $7.29 Jun 20, 2024 By ZNZ Holdings LLC
Aprea Therapeutics, Inc. Director Common Stock 4.4K $32.1K $7.29 Jun 20, 2024 Direct
Aprea Therapeutics, Inc. Director Stock Options (Right to Buy) 4.19K Jun 20, 2024 Direct
Aprea Therapeutics, Inc. Director Series A Non-Voting Convertible Preferred Stock 0 Aug 23, 2022 By ZNZ Holdings LLC
Aprea Therapeutics, Inc. Director Series A Non-Voting Convertible Preferred Stock 0 Aug 23, 2022 Direct

Insider Reports Filed by Rifat Pamukcu

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APRE Aprea Therapeutics, Inc. Jun 20, 2024 2 $0 4 Jun 21, 2024 Director
APRE Aprea Therapeutics, Inc. Aug 23, 2022 6 $0 4 Aug 24, 2023 Director
APRE Aprea Therapeutics, Inc. Jul 28, 2022 2 $0 4 Aug 1, 2022 Director
APRE Aprea Therapeutics, Inc. May 16, 2022 0 $0 3 May 26, 2022 Director